Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion.
Saito G, Kono M, Tsutsumi A, Koyanagi Y, Miyashita K, Kobayashi T, Hozumi H, Miki Y, Arai Y, Otsuki Y, Hashimoto D, Fujisawa T, Nakamura T, Suda T, Nakamura H. Saito G, et al. Intern Med. 2018 Aug 1;57(15):2227-2232. doi: 10.2169/internalmedicine.0302-17. Epub 2018 Mar 9. Intern Med. 2018. PMID: 29526945 Free PMC article.
IgG4-related disease presenting with combined pulmonary fibrosis and emphysema (CPFE).
Kono M, Nakamura Y, Oyama Y, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Enomoto Y, Kobayashi T, Miki Y, Hashimoto D, Enomoto N, Colby TV, Suda T, Nakamura H. Kono M, et al. Among authors: saito g. Respir Med Case Rep. 2018 Oct 3;25:257-260. doi: 10.1016/j.rmcr.2018.09.017. eCollection 2018. Respir Med Case Rep. 2018. PMID: 30302309 Free PMC article.
Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Kono M, Nakamura Y, Enomoto N, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Kobayashi T, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Inui N, Suda T, Nakamura H. Kono M, et al. Among authors: saito g. Respir Investig. 2019 Nov;57(6):552-560. doi: 10.1016/j.resinv.2019.07.003. Epub 2019 Aug 31. Respir Investig. 2019. PMID: 31477470
Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study.
Kawachi H, Tamiya M, Taniguchi Y, Yokoyama T, Yokoe S, Oya Y, Imaji M, Okabe F, Kanazu M, Sakata Y, Uematsu S, Tanaka S, Arai D, Saito G, Kobe H, Miyauchi E, Okada A, Hara S, Kumagai T. Kawachi H, et al. Among authors: saito g. JTO Clin Res Rep. 2022 Jun 3;3(7):100355. doi: 10.1016/j.jtocrr.2022.100355. eCollection 2022 Jul. JTO Clin Res Rep. 2022. PMID: 35769388 Free PMC article.
Chemotherapy with gemcitabine for unresectable intrahepatic cholangiocarcinoma in a patient undergoing maintenance hemodialysis.
Matsumoto K, Okamoto K, Namura Y, Kikuyama T, Saito G, Adachi T, Watanabe A, Tsunashima H, Katsukura N, Tsujikawa T, Kikuchi K, Matsui K, Doi S. Matsumoto K, et al. Among authors: saito g. Clin J Gastroenterol. 2021 Oct;14(5):1511-1516. doi: 10.1007/s12328-021-01478-4. Epub 2021 Jul 9. Clin J Gastroenterol. 2021. PMID: 34241805
Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.
Tamiya M, Fujikawa K, Suzuki H, Yokoyama T, Uenami T, Tamiya A, Sato Y, Saito G, Uchida J, Morita M, Hirashima T, Fukuda Y, Kanazu M, Hosoya K, Suzuki T, Ueno K, Fujimoto D, Kumagai T, Teramukai S. Tamiya M, et al. Among authors: saito g. Invest New Drugs. 2022 Apr;40(2):361-369. doi: 10.1007/s10637-021-01203-5. Epub 2022 Jan 28. Invest New Drugs. 2022. PMID: 35088212
321 results